The typical patient profile for whom MIC B12 represents good value: confirmed or suspected B12 deficiency, seeking energy improvement and modest weight-loss support, not ready for or not qualifying for GLP-1 therapy, willing to self-inject weekly
Hear from CEO Steve Fife, VP of R&D and Regulatory, Lisa Barnes, and Chief Sales Officer, Kristen Cunningham as they cover LV's strategy, marketing position, and long-term growth potential
It could also hint at suggestions for development policies and practices in order to minimise negative outcomes or implement adaptation and/or prevention measures
Lebrun LJ, Lenaerts K, Kiers D, Pais de Barros JP, Le Guern N, Plesnik J, et al
The Science Behind the Headlines In a 2025 randomised clinical trial published in JAMA Psychiatry, researchers investigated the effects of once-weekly semaglutide injections in adults with alcohol use disorder